Their results indicated a significant reduction in DNAM-1 expression on peritoneal NK cells from ovarian cancer patients compared to healthy donor NK cells (51.8% vs. 90.9%, respectively), whereas there was no significant difference in TIGIT expression. The gene discussed is TIGIT; the disease is ovarian carcinoma.